Rickey James Paul
Chief Financial Officer
Rickey James Paul has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Rickey James Paul is listed as Chief Financial Officer at Braveheart Bio, Inc. Inside the rolling window, Rickey James Paul reported 1 open-market purchase totaling $500K in BRVE and no open-market sales.
Companies traded
Other insiders at BRVE
Insider Buying
$500K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rickey James Paul made?
Rickey James Paul has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Rickey James Paul trade?
Rickey James Paul has filed SEC Form 4 disclosures for 1 company, including BRVE.
When was Rickey James Paul's most recent SEC Form 4 filing?
Rickey James Paul's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Rickey James Paul's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rickey James Paul is listed as Chief Financial Officer.
What is Rickey James Paul's total buy and sell value in the current window?
Inside the rolling retention window, Rickey James Paul bought $500K and sold $0 based on SEC Form 4 filings.
What was Rickey James Paul's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 27,777 BRVE shares on 2026-08-07, worth $500K, per SEC Form 4 filings.